State Street’s Cue Health HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-330,924
Closed -$62.4K – 4426
2024
Q1
$62.4K Hold
330,924
– – ﹤0.01% 4121
2023
Q4
$53.8K Hold
330,924
– – ﹤0.01% 4183
2023
Q3
$146K Hold
330,924
– – ﹤0.01% 4013
2023
Q2
$122K Sell
330,924
-1,850,676
-85% -$1.58M ﹤0.01% 4173
2023
Q1
$3.97M Buy
2,181,600
+53,649
+3% +$117K ﹤0.01% 3074
2022
Q4
$4.4M Buy
2,127,951
+476,796
+29% +$1.51M ﹤0.01% 3085
2022
Q3
$4.97M Buy
1,651,155
+249,009
+18% +$883K ﹤0.01% 3063
2022
Q2
$4.49M Buy
1,402,146
+1,180,150
+532% +$6.39M ﹤0.01% 3148
2022
Q1
$1.43M Buy
221,996
+68,224
+44% +$617K ﹤0.01% 3688
2021
Q4
$2.06M Buy
+153,772
New +$1.69M ﹤0.01% 3627

Other funds holding HLTH

State Street's HLTH Position: Q2 2024 in Review

State Street sold out of Cue Health (HLTH) in Q2 2024, closing a stake of 330,924 shares — an estimated $62.4K sold.

State Street first reported a position in HLTH in Q4 2021 and held it in 10 quarters. The position peaked at $4.97M in Q3 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • State Street reported no remaining Cue Health position as of Q2 2024 after selling out during the quarter.
  • State Street sold 330,924 Cue Health shares in Q2 2024, an estimated $62.4K.
  • State Street first reported a position in Cue Health in Q4 2021 and held it in 10 quarters.
  • State Street's Cue Health position peaked at $4.97M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.